Scott Gerald Meikle - 01 Feb 2022 Form 4 Insider Report for LAM RESEARCH CORP (LRCX)

Role
Senior Vice President
Signature
Leign Cramer by Power of Attorney
Issuer symbol
LRCX
Transactions as of
01 Feb 2022
Net transactions value
-$413,000
Form type
4
Filing time
02 Feb 2022, 15:38:03 UTC
Previous filing
16 Dec 2021
Next filing
09 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LRCX Common Stock Options Exercise $119,364 +628 +3.7% $190.07 17,652 01 Feb 2022 Direct F1, F2
transaction LRCX Common Stock Sale $370,520 -628 -3.6% $590.00 17,024 01 Feb 2022 Direct F1, F2
transaction LRCX Common Stock Options Exercise $12,726 +72 +0.42% $176.75 17,096 01 Feb 2022 Direct F1, F2
transaction LRCX Common Stock Sale $42,480 -72 -0.42% $590.00 17,024 01 Feb 2022 Direct F1, F2
holding LRCX Common Stock 151 01 Feb 2022 By 401(k)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LRCX Employee Stock Option (Right to Buy) Options Exercise $119,364 -628 -100% $190.07 0 01 Feb 2022 Common Stock 628 $190.07 Direct F3
transaction LRCX Employee Stock Option (Right to Buy) Options Exercise $12,726 -72 -1.1% $176.75 6,300 01 Feb 2022 Common Stock 72 $176.75 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 11, 2021.
F2 The amount reported includes shares subject to unvested Restricted Stock Units.
F3 The stock options will become exercisable in three equal installments on 03/02/2019, 03/02/2020, and 03/02/2021.
F4 The stock options will become exercisable in three equal installments on 03/02/2020, 03/02/2021, and 03/02/2022.